Stockholm:EKTAB

Invitation to the presentation of Elekta's second quarter 2021/22

STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day. The company's development will b...

2021-11-04 15:15 2079

Elekta establishes a framework for sustainability-linked bonds

STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established a Sustainability-Linked Bond Framework (SLB Framework) for issues of sustainability-linked bonds under itsMedium Term Note Program  (MTN-Program). Elekta is among the first companies inSweden to est...

2021-10-29 15:29 1520

Elekta's Board announces establishment of philanthropic Elekta Foundation

STOCKHOLM, Aug. 26, 2021 /PRNewswire/ -- At its Annual General Meeting on August 25, Elekta's (EKTA-B.ST) shareholders approved the Board of Directors' proposal to establish the Elekta Foundation. The Elekta Foundation's mission is an important part of Elekta's environmental, social, and governan...

2021-08-26 14:21 2520

Report from the Annual General Meeting 2021 in Elekta

STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta AB (publ) has held its Annual General Meeting on25 August 2021. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting was conducted by advance postal vote, without physical attendance. A statement from the CEO and P...

2021-08-25 20:50 3613

Elekta to address Indonesia's cancer care gap with direct presence

STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that is has established permanent legal entity inIndonesia's capital, Jakarta in order to address the unmet need for high quality, modern cancer care. Radiation therapy is a critical component in treating cancer and is c...

2021-08-25 14:43 2081

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to contin...

2021-07-23 21:02 7783

Data from 14 leading cancer centers presented at AAPM highlight global adoption of Elekta Unity MR-Linac

Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Uni...

2021-07-23 14:17 7009

Notice to the Annual General Meeting of Elekta AB (publ)

STOCKHOLM, July 21, 2021 /PRNewswire/ -- The shareholders of Elekta AB (publ), reg. no 556170-4015 are hereby convened to the Annual General Meeting to be held on Wednesday25 August 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be conducted wit...

2021-07-21 15:06 7529

Elekta optimizes treatment times for cancer patients via proactive service innovation

STOCKHOLM, July 7, 2021 /PRNewswire/ -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. Among these solutions ...

2021-07-07 14:38 31457

Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherap...

2021-06-17 14:38 14344

Elekta's new strategy to focus on growth and access to radiation therapy

STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO,Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the visi...

2021-06-07 20:44 12775

Elekta and Philips deepen strategic partnership in precise and individualized oncology care

STOCKHOLM and AMSTERDAM, June 7, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collab...

2021-06-07 16:02 5206

100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand

CHRISTCHURCH, New Zealand, June 1, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that St George's Hospital inChristchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction. Today, the innovative radiation therapy device is found in 14 count...

2021-06-01 15:07 3768

Year-end report, May-April 2020/21

Accelerated order growth STOCKHOLM, May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order. Installation volumes were similar to levels in the fourth quarter ...

2021-05-28 14:24 12281

Invitation to Elekta's Capital Markets Day 2021

STOCKHOLM, May 20, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites investors, analysts and financial media representatives to join Elekta's digital Capital Markets Day (CMD) onJune 7, 2021. Speakers at the event will include Gustaf Salford, President and CEO,Johan Adebäck, CFO, and several other ...

2021-05-20 17:03 7706

Invitation to the presentation of Elekta's fiscal year 2020/21

STOCKHOLM, May 10, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2020/21 at10:00 a.m. CEST on May 28. The year-end report will be published at 7:30 a.m. CET on the same day.The company's development will be presented by Elekta's Presid...

2021-05-10 17:43 1295

Report from the Extraordinary General Meeting 2021 in Elekta

STOCKHOLM, April 16, 2021 /PRNewswire/ -- Elekta AB (publ) (EKTA-B.ST) has held an Extraordinary General Meeting on Friday16 April 2021. Due to Covid-19, the Meeting was conducted by advance postal vote, without the physical attendance of shareholders, representatives or third parties. A summary ...

2021-04-16 16:59 6206

Notice to the Extraordinary General Meeting of Elekta AB (publ)

STOCKHOLM, March 19, 2021 /PRNewswire/ -- Shareholders of Elekta AB (publ), reg. no. 556170-4015, are hereby invited to attend the Extraordinary General Meeting to be held on Friday16 April 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be condu...

2021-03-19 21:30 4947

Elekta's Board of Directors proposes additional dividend of SEK 0.90 per share

STOCKHOLM, March 12, 2021 /PRNewswire/ -- The Board of Directors of Elekta (EKTA-B.ST) proposes an extra dividend for the fiscal year 2019/20. According to the communication in connection with the ordinary dividend, the Board announced that Elekta may propose an additional dividend so that the t...

2021-03-12 01:12 3934

Elekta wins lawsuit against Livian GmbH

STOCKHOLM, March 8, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that theLondon Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH). The arbitration, reported in the latest interim report (Q3 2020/21), is now f...

2021-03-08 16:49 2171
123